Key message
There is paucity of data on peanut OIT long-term effects and quality of
life impact. PPOIT induces sustained unresponsiveness that persists to
3-years post-treatment in a high proportion of treated patients, and
leads to long-lasting improvement in health-related quality of life,
supporting previous findings from a proof-of-concept randomized trial.
PPOIT provides lasting benefits for children with peanut allergy,
offering an approach to induce long-term sustained unresponsiveness and
improve health-related quality of life.